Destination Wealth Management Bristol Myers Squibb CO Transaction History

Destination Wealth Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $8 - $4,840	63 Added 2.05%	3,136 $223,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $223,161 - $245,778	3,073 New	3,073 $237,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $178,989 - $209,662	-3,025 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $120,414 - $131,131	-1,945 Reduced 39.13%	3,025 $202,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $294,919 - $331,697	4,970 New	4,970 $314,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $42,684 - $50,608	-998 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $24,541 - $27,137	-550 Reduced 35.53%	998 $45,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $42,096 - $50,195	-933 Reduced 37.61%	1,548 $74,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $35,643 - $46,221	-731 Reduced 22.76%	2,481 $129,000
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $27,870 - $31,436	505 Added 18.66%	3,212 $199,000
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $6,063 - $7,557	-120 Reduced 4.24%	2,707 $150,000
Q1 2018 Apr 05, 2018	BUY	$59.92 - $68.98 $169,393 - $195,006	2,827 New	2,827 $179,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.